Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaush MeditechHKSE:02407 +0.61%67 FCF Yield % is 16.62 as of Jul. 20, 2026, which is 220% above its 10-year median of 5.19. GuruFocus rates HKSE:02407 with a GF Score™ of 67/100 and a GF Value™ of HK$13.39 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Gaush Meditech ranks better than 97.3% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Gaush Meditech's FCF Yield % or its related term are showing as below:
HKSE:02407'
s FCF Yield % Range Over the Past 10 Years
Min: 2.01 Med: 5.19 Max: 17.63
Current: 16.62
During the past 7 years, the highest FCF Yield % of Gaush Meditech was 17.63%. The lowest was 2.01%. And the median was 5.19%.
HKSE:02407's FCF Yield % is ranked better than 97.3% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: -0.44
vs HKSE:02407: 16.62
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Gaush Meditech FCF Yield % Related Terms
Gaush Meditech FCF Yield % Historical Data
* Premium members only.
The historical data trend for Gaush Meditech's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02407 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Gaush Meditech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaush Meditech FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Gaush Meditech's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaush Meditech (HKSE:02407) has a FCF Yield % of 16.62 as of Jul. 20, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Gaush Meditech and its competitors. This is 220% above median its historical median of 5.19. Over the past decade, Gaush Meditech's FCF Yield % has ranged from 2.01 to 17.63. According to the industry distribution chart, Gaush Meditech ranks #23 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 2.7%.
Is Gaush Meditech's FCF Yield % too high?
Gaush Meditech's current FCF Yield % of 16.62 is 220% above median its 10-year median of 5.19. Over the past 10 years, this metric has ranged from a low of 2.01 to a high of 17.63. Based on the distribution chart, Gaush Meditech ranks #23 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Gaush Meditech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gaush Meditech's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Gaush Meditech ranks #23 out of 853 companies for FCF Yield %. This places Gaush Meditech in the top 3% of its industry — outperforming the majority of peers. Historically, Gaush Meditech's own FCF Yield % has ranged from 2.01 to 17.63 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Gaush Meditech and its competitors. Gaush Meditech's current FCF Yield % is 16.62, which is 220% above median its own 10-year median of 5.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaush Meditech stock overvalued right now?
Based on GuruFocus' analysis, Gaush Meditech (HKSE:02407) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.39, compared to a current price of HK$4.96 — trading 63% below its estimated fair value. The current FCF Yield % is 16.62, which is 220% above median its 10-year median of 5.19. Gaush Meditech's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Gaush Meditech (HKSE:02407), the current FCF Yield % is 16.62 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gaush Meditech (HKSE:02407) Overvalued in 2026?
Based on GuruFocus' analysis, Gaush Meditech stock appears to be undervalued.
The current stock price of HK$4.96 is trading 63% below its estimated GF Value™ of HK$13.39.
GuruFocus considers Gaush Meditech to be Possible Value Trap.
Key valuation signals for HKSE:02407:
FCF Yield %: 16.62 (220% above median its 10-year median of 5.19)
GF Value™: HK$13.39 vs. price of HK$4.96 (63% below fair value)
No single metric tells the full story. See the HKSE:02407 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
67GF Score
Get the complete analysis for HKSE:02407
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02407 has been successfully added to your 
